Target Entity
Name: Saarathi Healthcare Private Limited
Type of Deal
Acquisition of minority stake (24%) to achieve 100% ownership
Stake/Capacity
Percentage stake acquired: 24%
Total stake after acquisition: 100%
Total paid-up Equity Share Capital of Target Entity: ₹82.50 lakh
Deal Value
Consideration: ₹14,22,50,000 (₹14.23 crore)
Number of shares acquired: 1,98,000
Payment structure: Cash consideration
Financial Impact
Target Entity turnover for financial year ended March 31, 2026: ₹1844.99 lakh
Historical turnover:
- 2024-2025: ₹1629.47 lakh
- 2023-2024: ₹1332.51 lakh
Business description: The Target Entity is engaged in running disease management, early diagnosis, screening with POC devices, disease awareness, and access programs across therapy using digital tools as well as physical interaction models.
Timeline
Acquisition completed as of September 17, 2026 (no future completion timeline required)
Strategic Rationale
The transaction will further expand QMS Medical Allied Services Limited's total addressable market in the value-added healthcare business, aligning with the company's key strategic priorities.
Approval Status
Transaction completed and approved
Reference Regulation
SEBI Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026
Additional Details
- Not a related party transaction
- Promoter/promoter group/group companies have no interest in the entity being acquired
- Target Entity incorporated on October 21, 2010
- Headquartered at Thane, Maharashtra
- No governmental or regulatory approvals required for the acquisition